Global Pharmaceutical Company Uses Our Genome Editing Technology for Developing Cell Therapy
Technology Developed at Rutgers Sublicensed to Global Biopharmaceutical Company
Shengkan Jin
Victor Shengkan Jin Received Edison Patent Award in Biotechnology
Victor Shengkan Jin Received Edison Patent Award in Biotechnology
Our Work Featured in Genetic Engineering and Biotechnology News
https://www.genengnews.com/news/now-on-base-rutgers-team-reveals-new-genome-editing-approach/ Now on Base, Rutgers Team Reveals New Genome Editing Approach
Our Genome Editing Platform is Highlighted in “CRISPR 2.0: Base Editing in the Groove”
CRISPR 2.0: Base Editing in the Groove